The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System

September 12, 2023 updated by: University Hospital, Ghent

Persons with an injury of the central nervous system clearly experience motor impairments. Among the most commonly described consequences are gait abnormalities and impaired balance. Although these are undeniably linked, they are also influenced by other factors. A recent systematic review (Xie, 2022) reports impaired balance, the presence of depression or anxiety, and decreased function of the lower limbs as important risk factors for fear of falling in persons after a stroke. Also for people with a spinal cord injury, the fear of falling has a major impact on their level of participation and quality of life (Sing, 2021). Preventing falls and reducing fear of falling is an important part of neurological rehabilitation programs as it is known that fear of falling has a negative impact on the patient's activity level. This in turn will lead to an increased risk of falling and a negative effect on neurological recovery due to insufficiently practicing their balance while walking.

Since 2019 the rehabilitation center of UZ gent offers GRAIL training. This device aims to train walking balance and gait adaptability in a virtual environment. Patients who are admitted and/or undergoing ambulatory rehabilitation at UZ Gent are given the opportunity to complete a 5-week training schedule on the GRAIL. Before and after this training intervention period, the investigators evaluate the gait pattern of these patients. After the training period, the patients also complete a questionnaire about their experience while training on the GRAIL and often also indicate that they become more confident in their own balance when walking. That is why the researchers now also want to measure this.

Research questions:

  1. Do people with high confidence in their balance when walking differ from those with low confidence in their balance when walking?
  2. Does GRAIL training have a different effect on confidence in balance than traditional rehabilitation? To answer the 2nd research question, patients who follow the traditional rehabilitation (control group) also receive the same tests as the people who follow GRAIL training.

Randomization (prepared in advance via a computer program) determines who will follow the GRAIL training and who will follow the traditional rehabilitation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ghent, Belgium, 9000
        • Recruiting
        • Ghent University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Persons who are admitted to the rehabilitation center of the Ghent University Hospital (in and outpatient) and suffered a stroke, spinal cord injury of traumatic brain injury
  • Persons have to be able to walk for at least 6 minutes without the need of a person to help and with minimal help of a walking device. (level FAC 2 or higher)
  • Participants who understand orders during the assessment and intervention.

Exclusion Criteria:

  • Other neurological conditions (MS, Parkinson, ...)
  • Orthopedic trauma or recent acute trauma that influence walking ability.
  • Body weight exceeds 120 kg.
  • Severe dizziness that makes it impossible to practice in standing position.
  • Cardiac or pulmonary problems that require monitoring during exercising.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GRAIL group

Participants will receive 5 weeks of training on the GRAIL device, which is focused on training balance during walking.

Therapy frequency: 2*30 minutes per week.

Participants will receive dynamic balance training while walking on the GRAIL device.
Active Comparator: Traditional gait rehabilitation

Participant will receiver traditional gait rehabilitation which also includes training balance during walking.

Therapy frequency in both groups is equal.

Participants will receive traditional gait rehabilitation that also includes balance training while walking but not on the GRAIL device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait speed (m/s)
Time Frame: Before the intervention
Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking on the treadmill.
Before the intervention
Step length (m)
Time Frame: Before intervention

Step length (m)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Before intervention
Step width (m)
Time Frame: Before intervention

Step width (m)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Before intervention
Cadence (steps per minute)
Time Frame: Before intervention

Cadence (steps per minute)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Before intervention
Cadence (steps per minute)
Time Frame: Within one week after the intervention

Cadence (steps per minute)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Within one week after the intervention
Time in swing and stance phase (s)
Time Frame: Before intervention

Time in swing and stance phase (s)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Before intervention
Time in swing and stance phase (s)
Time Frame: Within one week after the intervention

Time in swing and stance phase (s)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Within one week after the intervention
Step width (m)
Time Frame: Within one week after the intervention

step width (m)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Within one week after the intervention
Step length (m)
Time Frame: Within one week after the intervention

Step length (m)

  • Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention).
  • Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period)
  • Difference in spatiotemporal parameters during normal walking before and after intervention.
Within one week after the intervention
10 meter walk test
Time Frame: Before intervention

Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking overground.

Change in overground walking speed before and after intervention.

Before intervention
10 meter walk test
Time Frame: Within one week after the intervention

Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking overground.

Change in overground walking speed before and after intervention.

Within one week after the intervention
Margins of stability
Time Frame: Before intervention
Dynamic balance during walking measured during normal walking and during the balance task.
Before intervention
Margins of stability
Time Frame: Within one week after the intervention
Dynamic balance during walking measured during normal walking and during the balance task.
Within one week after the intervention
Activity-specific Balance Confidence (ABC) scale
Time Frame: Before intervention
Balance confidence scored by the participant (questionnaire) per item (16 items) geeft participant weer hoeveel vertrouwen hij heeft in dit item (0-100%) Hogere score is meer vertrouwen.
Before intervention
Activity-specific Balance Confidence (ABC) scale
Time Frame: Within one week after the intervention
Balance confidence scored by the participant (questionnaire) per item (16 items) geeft participant weer hoeveel vertrouwen hij heeft in dit item (0-100%) Hogere score is meer vertrouwen.
Within one week after the intervention
Visual analogue scale score to assess task specific confidence
Time Frame: Before intervention

Participants are asked to score the level of confidence that they have that they can complete the balance task (score 0-10).

Higher score is more confidence.

Before intervention
Visual analogue scale score to assess task specific restraints
Time Frame: Before intervention

Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10).

Higher score is more restraint.

Before intervention
Visual analogue scale score to assess task specific confidence
Time Frame: Within one week after the intervention

Participants are asked to score the level of confidence that they have that they can complete the balance task (score 0-10).

Higher score is more confidence.Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10).

Within one week after the intervention
Visual analogue scale score to assess task specific restraints
Time Frame: Within one week after the intervention

Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10).

Higher score is more restraint.

Within one week after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life using the SF36_C questionnaire
Time Frame: Before intervention

Questionnaire to assess the quality of life (SF36_C)

  • Do persons with high balance confidence have better quality of life?
  • Does the quality of life change after the intervention?
Before intervention
Quality of life using the SF36_C questionnaire
Time Frame: Within one week after the intervention

Questionnaire to assess the quality of life (SF36_C)

  • Do persons with high balance confidence have better quality of life?
  • Does the quality of life change after the intervention?
Within one week after the intervention
Anxiety and depression
Time Frame: Before intervention

Hospital anxiety and depression scale (HADS)

  • Do persons with high balance confidence have less anxiety and depression?
  • Does the anxiety and depression change after the intervention?
Before intervention
Anxiety and depression
Time Frame: Within one week after the intervention

Hospital anxiety and depression scale (HADS)

  • Do persons with high balance confidence have less anxiety and depression?
  • Does the anxiety and depression change after the intervention?
Within one week after the intervention
Gait quality
Time Frame: Within one week after the intervention
Joint angles of lower limbs and trunk (degree) Do persons with high balance confidence walk different than persons with low balance confidence.
Within one week after the intervention
Scoring on a visual analogue scale to assess fear of falling
Time Frame: Before intervention

Visual analogue scale (0-10) to indicate fear of falling during walking overground in the rehabilitation center and during walking on the treadmill.

Higher score is more fear to fall.

Before intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anke Van Bladel, PhD, Ghent University Hopsital / Ghent University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2022

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

August 4, 2022

First Submitted That Met QC Criteria

August 12, 2022

First Posted (Actual)

August 16, 2022

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Dynamic balance training

3
Subscribe